Home/Filings/4/0001460878-20-000005
4//SEC Filing

Newton Todd 4

Accession 0001460878-20-000005

CIK 0001251769other

Filed

May 10, 8:00 PM ET

Accepted

May 11, 4:59 PM ET

Size

8.0 KB

Accession

0001460878-20-000005

Insider Transaction Report

Form 4
Period: 2020-05-07
Newton Todd
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2020-05-07+77,075408,827 total
  • Award

    Stock Option (Right to Buy)

    2020-05-07$2.08/sh+115,094$239,396511,604 total
    Exercise: $2.08Exp: 2030-05-07Common Stock (115,094 underlying)
Footnotes (2)
  • [F1]Represents the grant of Restricted Stock Units ("RSU"). Each RSU provides the Reporting Person with a contingent right to receive one share of the Issuer's common stock pursuant to the Apollo Endosurgery, Inc. 2017 Equity Incentive Plan. The RSUs vest in equal annual installments over three years commencing on the grant date, subject to the Reporting Person providing continuous service to the Issuer through each such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Apollo Endosurgery, Inc. 2017 Incentive Plan.
  • [F2]The shares underlying the option shall vest as to 33% on the first anniversary of the grant date and the remainder will vest in equal monthly installments over the following two years, subject to the Reporting Person providing continuous service to the Issuer through each such date. Accelerated vesting may occur in the event of a Change in Control, as that term is defined in the Apollo Endosurgery, Inc. 2017 Equity Incentive Plan.

Issuer

Apollo Endosurgery, Inc.

CIK 0001251769

Entity typeother

Related Parties

1
  • filerCIK 0001460878

Filing Metadata

Form type
4
Filed
May 10, 8:00 PM ET
Accepted
May 11, 4:59 PM ET
Size
8.0 KB